Someday, the story of Martin Shkreli will come to an end. But before that happens we can revel in a douche spectacle that seems to treat onlookers to an endless buffet of bizarre plot twists. The almost willfully insufferable Shkreli has led us through
In today's WTF news Martin Shkreli, pharmaceutical company acquirer turned Wu-Tang $2 million album procurer, fired back at Ghostface Killah for the Clansman's recent comments questioning his legitimacy as owner of Once Upon A Time In Shaolin. And he
In today's WTF news Martin Shkreli, pharmaceutical company acquirer turned Wu-Tang $2 million album procurer, fired back at Ghostface Killah for the Clansman's recent comments questioning his legitimacy as owner of Once Upon A Time In Shaolin. And he
Martin Shkreli has made a name for himself by talking in the face of federal securities fraud charges, as well as fighting back against claims that he embodies greed in the pharmaceutical industry.
No matter where you turn these days, you cannot avoid Martin Shkreli. He is the man who achieved infamy by cornering the market on a drug used to fight protozoal infections in people with AIDS and people with malaria. That drug used to cost $13.50 a pill.